Evaluating the Safety and Tolerability of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
Clinical trial NCT02475655 · COMPLETED
Trial details
- NCT number
- NCT02475655
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-16
- Primary completion
- 2018-02-18
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.